| __timestamp | Teva Pharmaceutical Industries Limited | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9216000000 | 54823000000 |
| Thursday, January 1, 2015 | 8296000000 | 76585000000 |
| Friday, January 1, 2016 | 10044000000 | 87477000000 |
| Sunday, January 1, 2017 | 11560000000 | 89052000000 |
| Monday, January 1, 2018 | 10558000000 | 100745000000 |
| Tuesday, January 1, 2019 | 9351000000 | 91915000000 |
| Wednesday, January 1, 2020 | 8933000000 | 95905000000 |
| Friday, January 1, 2021 | 8284000000 | 104442000000 |
| Saturday, January 1, 2022 | 7952000000 | 104437000000 |
| Sunday, January 1, 2023 | 8200000000 | 112009000000 |
| Monday, January 1, 2024 | 8480000000 | 121134000000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of pharmaceuticals and retail, understanding cost efficiency is crucial. Teva Pharmaceutical Industries Limited and Walgreens Boots Alliance, Inc. have been pivotal players in their respective sectors. From 2014 to 2023, Walgreens consistently outpaced Teva in cost of revenue, with Walgreens' costs peaking at over 120% higher than Teva's in 2023. This trend highlights Walgreens' expansive operations and market reach. Teva, on the other hand, maintained a more stable cost structure, with fluctuations of around 20% over the decade. Notably, 2024 data for Teva is missing, indicating potential reporting delays or strategic shifts. This analysis underscores the importance of cost management in maintaining competitive advantage, especially in industries where margins are tight. As these companies navigate future challenges, their ability to manage costs will be a key determinant of their success.
Cost Insights: Breaking Down Novo Nordisk A/S and Walgreens Boots Alliance, Inc.'s Expenses
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Pharming Group N.V.
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Veracyte, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Viatris Inc. and Walgreens Boots Alliance, Inc.'s Expenses
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Walgreens Boots Alliance, Inc.
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Alkermes plc's Expenses
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: Walgreens Boots Alliance, Inc. and Mesoblast Limited